Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: A placebo-controlled trial
Authors:
- J. H. VrankenJVJ. H. Vranken
- M. G.W. DijkgraafMDM. G.W. Dijkgraaf
- M. R. KruisMKM. R. Kruis
- N. T. van DasselaarNDN. T. van Dasselaar
- M. H. van der VegtMVM. H. van der Vegt
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 118 (1) , 224-231
Abstract
The efficacy of 50 and 75 mg S(+)-ketamine administered daily by an iontophoresis-assisted transdermal drug delivery system was tested against placebo in a randomized, double-blind design in 33 patients with central neuropathic pain. At baseline and 1 week after the start of treatment subjects were evaluated with standard measures of efficacy: pain intensity measured by visual analog scale (VAS), health status (Pain Disability Index and EQ-5D) and quality of life (SF-36). Safety assessment included incidence and intensity of adverse events. No significant differences in pain scores (VAS) were observed between the ketamine groups and placebo during the course of the trial. Corrected for baseline levels, daily 50 mg S(+)-ketamine did not improve patient's health status or quality of life compared with placebo treatment. However, daily 75 mg S(+)-ketamine showed significant improvements on the Pain Disability Index, on the EQ-5D, and on the SF-36 except for the role-physical functioning and general health perception. Iontophoretic administration of S(+)-ketamine was well tolerated with a low incidence of adverse events (mild and transient in nature, resolving spontaneously). Iontophoretic administration of S(+)-ketamine was not more effective than placebo treatment in reducing pain scores in patients with severe central neuropathic pain. However, iontophoretic administration of 75 mg S(+)-ketamine improved the health status and the quality of life in these patients.Keywords
This publication has 34 references indexed in Scilit:
- Topical 2% Amitriptyline and 1% Ketamine in Neuropathic Pain SyndromesAnesthesiology, 2005
- Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1Regional Anesthesia & Pain Medicine, 2002
- Analgesic Effects of Ketamine Ointment in Patients with Complex Regional Pain Syndrome Type 1Regional Anesthesia & Pain Medicine, 2002
- Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain ManagementJournal of Pain and Symptom Management, 2000
- Histological Findings After Long-Term Infusion of Intrathecal Ketamine for Chronic PainJournal of Pain and Symptom Management, 1999
- Analgesic Effect of Oral Ketamine in Chronic Neuropathic Pain of Spinal OriginJournal of Pain and Symptom Management, 1999
- Clinical Experience with Oral KetamineJournal of Pain and Symptom Management, 1999
- The Pain Disability Index: Factor structure and normative dataArchives of Physical Medicine and Rehabilitation, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient GroupsMedical Care, 1994
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990